Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-075196

Aclaris Therapeutics, Inc. · ACRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
James Healy
10% Owner
Period of report
Oct 13, 2015
Accepted (ET)
Oct 13, 2015 · 1:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557746

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Oct 13, 2015C1,880,390—A1,880,390D
Common StockF3Oct 13, 2015P409,090$11.00A2,289,480D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF3,F2—Oct 13, 2015C2,000,000D——Common Stock579,7100D
Series B Preferred StockF3,F2—Oct 13, 2015C2,424,242D——Common Stock702,6780D
Series C Preferred StockF3,F2—Oct 13, 2015C2,063,107D——Common Stock598,0020D

Explanation of responses